Pattern fidelity depends on matching the photomask, ultraviolet exposure, and photoresist response. The mask determines which surface regions receive light, while the resist converts that exposure into a developable pattern. Because the pattern is formed before etching or deposition, errors at this stage can be carried into the final structure, affecting the precision of biological devices.
Photoresist chemistry determines which material remains after development. In one formulation, exposure makes the illuminated regions removable; in another, development removes the unexposed regions instead. This distinction changes the polarity of the transferred pattern without changing the basic exposure sequence, allowing the same type of process to create different surface layouts for research devices.
After development, the remaining resist identifies the regions that should be protected or left available during a subsequent fabrication step. Etching can use this patterned layer to shape the underlying surface, whereas deposition can place material according to the same layout. Thus, development links the optical exposure stage to the physical structure ultimately used in a biological experiment.
A typical workflow starts by placing a light-sensitive photoresist on the target surface, aligning a photomask, and exposing selected regions to ultraviolet light. Development then removes the exposed or unexposed resist, according to its chemistry. The resulting pattern is used for etching or deposition, producing the channels, sensor features, or culture structures required by the device.
Photolithography enables microfluidic platforms to contain patterned channels and other structures that organize fluid movement. These geometries can help establish controlled flow and gradients, giving experiments a reproducible physical environment rather than relying on uncontrolled fluid distribution. In biology, that control supports studies in which cells experience defined positions or fluid conditions.
Within biology, the fabricated structures serve as experimental platforms rather than merely finished components. Microfluidic devices can support cell-behavior studies, while biosensors provide patterned architectures for diagnostic work. Cell-culture and tissue-engineering platforms use the same precision to position cells or shape their environment, and these systems can be applied to examining drug responses.